DexCom, Inc. (0A4M.L)
| Previous close | 75.06 |
| Open | 74.93 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 74.01 - 74.95 |
| 52-week range | 74.01 - 74.95 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | 1.07 |
| PE ratio (TTM) | 151.35 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Come Chill at Dexcom’s ‘No Pricks Parlour’ With Ed Gamble for Diabetes Awareness Week, Celebrating You!
LONDON, June 13, 2022--Come chill with us! This week is Diabetes Awareness Week and DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring (rt-CGM) for people with diabetes, is honouring the theme of ‘celebrating you’ with its ‘No Pricks Parlour’, a pop-up ice cream van at London’s South Bank. Open tomorrow, Tuesday 14 June, for one day only, everyone is invited to enjoy free ice cream along with the opportunity to learn about the importance of access to finger
- Business Wire
Dexcom to Showcase Expanded CGM Portfolio and Industry-leading Connectivity at 82nd Scientific Sessions of the American Diabetes Association
SAN DIEGO, June 02, 2022--DEXCOM TO SHOWCASE EXPANDED CGM PORTFOLIO AND INDUSTRY-LEADING CONNECTIVITY AT 82ND SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION
- Business Wire
Prince Edward Island Becomes a National Leader in Providing Coverage for Dexcom G6 Continuous Glucose Monitoring System for Canadians With Diabetes
BURNABY, British Columbia, June 01, 2022--Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (rtCGM), announced today that people with type 1 and type 2 diabetes age two and over on multiple daily injections of insulin (three or more) or who use an insulin pump may now be eligible for public coverage of the Dexcom G6 CGM System through Prince Edward Island’s Diabetes Glucose Sensor Program.
